Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Excellent performance of Hemoccult Sensa in organised colorectal cancer screening.

Kershenbaum A, Flugelman A, Lejbkowicz F, Arad H, Rennert G.

Eur J Cancer. 2013 Mar;49(4):923-30. doi: 10.1016/j.ejca.2012.09.020. Epub 2012 Oct 22.

PMID:
23099005
2.

A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.

Greenberg PD, Bertario L, Gnauck R, Kronborg O, Hardcastle JD, Epstein MS, Sadowski D, Sudduth R, Zuckerman GR, Rockey DC.

Am J Gastroenterol. 2000 May;95(5):1331-8.

PMID:
10811348
3.

A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population.

Wong BC, Wong WM, Cheung KL, Tong TS, Rozen P, Young GP, Chu KW, Ho J, Law WL, Tung HM, Lai KC, Hu WH, Chan CK, Lam SK.

Aliment Pharmacol Ther. 2003 Nov 1;18(9):941-6.

4.

Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer.

Castiglione G, Zappa M, Grazzini G, Mazzotta A, Biagini M, Salvadori P, Ciatto S.

Br J Cancer. 1996 Jul;74(1):141-4.

5.

Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.

Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsène D, Boutreux S, Tichet J, Launoy G.

Gut. 2007 Feb;56(2):210-4. Epub 2006 Aug 4.

6.

A Comparison of the Cost-Effectiveness of Fecal Occult Blood Tests with Different Test Characteristics in the Context of Annual Screening in the Medicare Population [Internet].

van Ballegooijen M, Habbema JDF, Boer R, Zauber AG, Brown ML.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2003 Aug 9.

7.

Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.

Faivre J, Dancourt V, Manfredi S, Denis B, Durand G, Gendre I, Bidan JM, Jard C, Levillain R, Jung S, Viguier J, Dorval E.

Dig Liver Dis. 2012 Aug;44(8):700-4. doi: 10.1016/j.dld.2012.03.015. Epub 2012 Apr 26.

PMID:
22542582
8.

Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer.

Faivre J, Dancourt V, Denis B, Dorval E, Piette C, Perrin P, Bidan JM, Jard C, Jung S, Levillain R, Viguier J, Bretagne JF.

Eur J Cancer. 2012 Nov;48(16):2969-76. doi: 10.1016/j.ejca.2012.04.007. Epub 2012 May 7.

PMID:
22572481
9.

Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching.

Leuraud K, Jezewski-Serra D, Viguier J, Salines E.

Cancer Epidemiol. 2013 Dec;37(6):959-67. doi: 10.1016/j.canep.2013.07.008. Epub 2013 Sep 12.

PMID:
24035240
10.

Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.

Hughes K, Leggett B, Del Mar C, Croese J, Fairley S, Masson J, Aitken J, Clavarino A, Janda M, Stanton WR, Tong S, Newman B.

Aust N Z J Public Health. 2005 Aug;29(4):358-64.

PMID:
16222934
11.

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E.

Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25.

PMID:
18482589
12.

Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.

Hamza S, Dancourt V, Lejeune C, Bidan JM, Lepage C, Faivre J.

Eur J Cancer. 2013 Aug;49(12):2727-33. doi: 10.1016/j.ejca.2013.03.023. Epub 2013 Apr 16.

PMID:
23601670
13.

Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.

Levin B, Hess K, Johnson C.

Arch Intern Med. 1997 May 12;157(9):970-6.

PMID:
9140267
14.

A comparison of fecal occult-blood tests for colorectal-cancer screening.

Allison JE, Tekawa IS, Ransom LJ, Adrain AL.

N Engl J Med. 1996 Jan 18;334(3):155-9.

16.

Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report.

Young GP, St John DJ, Winawer SJ, Rozen P; WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy).

Am J Gastroenterol. 2002 Oct;97(10):2499-507.

PMID:
12385430
17.

Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms.

Dancourt V, Lejeune C, Lepage C, Gailliard MC, Meny B, Faivre J.

Eur J Cancer. 2008 Oct;44(15):2254-8. doi: 10.1016/j.ejca.2008.06.041. Epub 2008 Aug 27.

PMID:
18760592
18.

Earlier stages of colorectal cancer detected with immunochemical faecal occult blood tests.

van Rossum LG, van Rijn AF, van Munster IP, Jansen JB, Fockens P, Laheij RJ, Dekker E.

Neth J Med. 2009 May;67(5):182-6.

19.

Evaluation of new occult blood tests for detection of colorectal neoplasia.

St John DJ, Young GP, Alexeyeff MA, Deacon MC, Cuthbertson AM, Macrae FA, Penfold JC.

Gastroenterology. 1993 Jun;104(6):1661-8.

PMID:
8500724
20.

Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test.

Denis B, Ruetsch M, Strentz P, Vogel JY, Guth F, Boyaval JM, Pagnon X, Ebelin JF, Gendre I, Perrin P.

Gut. 2007 Nov;56(11):1579-84. Epub 2007 Jul 6.

Supplemental Content

Support Center